We previously described that NFkB activity, one of the most important signaling pathways in inflammation, is increased in BAP1-negative UM [52]; here we show that miR-155 is elevated in M3 tumours which we know are mostly BAP1-negative. The gene discussed is NFKB1; the disease is neoplasm.